[RESULTS OF THE TOTAL CAVA-PULMONARY CONNECTION PROCEDURE WITH CORRECTION OF ATRIO-VENTRICULAR VALVES IN PATIENTS OF

Klinichna Khirurhiia
|October 2, 2018
PubMed

Insights

This study improved management for single ventricle patients undergoing total cavopulmonary connection (TCPC) and atrioventricular valve (AVV) repair. A complex approach using multiple plasty procedures, including fiber ring stabilization, achieved optimal results in 92% of patients.

Area of Science:

  • Cardiovascular Surgery
  • Pediatric Cardiology

Background:

  • Single ventricle physiology presents complex surgical challenges.
  • Atrioventricular valve insufficiency is a common complication after total cavopulmonary connection (TCPC).

Purpose of the Study:

  • To enhance patient management following TCPC with atrioventricular valve (AVV) insufficiency.
  • To evaluate the outcomes of complex AVV repair strategies in single ventricle patients.

Main Methods:

  • Analysis of immediate and middle-term results in 132 patients who underwent TCPC from 2005-2015.
  • Focus on a subgroup of 24 patients with moderate to severe systemic AVV insufficiency.
  • Application of multiple plasty procedures, including fiber ring stabilization, for AVV correction.

Main Results:

  • Successful early and middle-term outcomes were achieved in 92% of the selected patient cohort.
  • Multiple reconstructive procedures were necessary in 8 patients undergoing AVV correction.
  • Complex surgical strategies, particularly fiber ring stabilization, correlated with optimal results.

Conclusions:

  • A comprehensive surgical approach combining various plasty techniques is crucial for optimal AVV correction in TCPC patients.
  • Fiber ring stabilization techniques significantly contribute to achieving superior outcomes in managing AVV insufficiency.
  • Improved patient management strategies can lead to better long-term results for single ventricle physiology.

Related Concept Videos

Anatomy of the Heart01:27

Anatomy of the Heart

The human heart is made up of three layers of tissue that are surrounded by the pericardium, a membrane that protects and confines the heart. The outermost layer, closest to the pericardium, is the epicardium. The pericardial cavity separates the pericardium from the epicardium. Beneath the epicardium is the myocardium, the middle layer, and the endocardium, the innermost layer. There are four chambers of the heart: the right atrium, the right ventricle, the left atrium, and the left ventricle.
119.9K
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
238
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
701
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
261
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
217
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
255